These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10643913)

  • 1. An automated biological assay to determine levels of the trypanocidal drug melarsoprol in biological fluids.
    Onyango JD; Burri C; Brun R
    Acta Trop; 2000 Jan; 74(1):95-100. PubMed ID: 10643913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro bioassay for quantification of melarsoprol in serum and cerebrospinal fluid.
    Burri C; Brun R
    Trop Med Parasitol; 1992 Dec; 43(4):223-5. PubMed ID: 1293724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepancy in plasma melarsoprol concentrations between HPLC and bioassay methods in patients with T. gambiense sleeping sickness indicates that melarsoprol is metabolized.
    Bronner U; Brun R; Doua F; Ericsson O; Burri C; Keiser J; Miézan TW; Boa YF; Rombo L; Gustafsson LL
    Trop Med Int Health; 1998 Nov; 3(11):913-7. PubMed ID: 9855405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of melarsoprol in biological fluids by high-performance liquid chromatography and characterisation of two stereoisomers by nuclear magnetic resonance spectroscopy.
    Ericsson O; Schweda EK; Bronner U; Rombo L; Fridén M; Gustafsson LL
    J Chromatogr B Biomed Sci Appl; 1997 Mar; 690(1-2):243-51. PubMed ID: 9106049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ELISA assay for melarsoprol.
    Maes L; Doua F; Hamers R
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):557-60. PubMed ID: 3197252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the trypanocidal drug melarsoprol and its conversion products in biological fluids with HPLC-ICPMS/ESMS.
    Raber G; Raber T; Raml R; Murko M; Magnes C; Francesconi KA
    Talanta; 2013 Nov; 116():876-81. PubMed ID: 24148488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations of the metabolites of the trypanocidal drug melarsoprol.
    Keiser J; Ericsson O; Burri C
    Clin Pharmacol Ther; 2000 May; 67(5):478-88. PubMed ID: 10824626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro.
    Räz B; Iten M; Grether-Bühler Y; Kaminsky R; Brun R
    Acta Trop; 1997 Nov; 68(2):139-47. PubMed ID: 9386789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic properties of the trypanocidal drug melarsoprol.
    Burri C; Baltz T; Giroud C; Doua F; Welker HA; Brun R
    Chemotherapy; 1993; 39(4):225-34. PubMed ID: 8391966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phenomenon of treatment failures in Human African Trypanosomiasis.
    Brun R; Schumacher R; Schmid C; Kunz C; Burri C
    Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda.
    Matovu E; Enyaru JC; Legros D; Schmid C; Seebeck T; Kaminsky R
    Trop Med Int Health; 2001 May; 6(5):407-11. PubMed ID: 11348535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a rat pheochromocytoma (PC12)-based cell survival assay for determining biological potency of recombinant human nerve growth factor.
    Gazzano-Santoro H; Chen A; Casto B; Chu H; Gilkerson E; Mukku V; Canova-Davis E; Kotts C
    J Pharm Biomed Anal; 1999 Dec; 21(5):945-59. PubMed ID: 10703962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The monitoring of trypanocidal treatment with a sensitive ELISA method for measuring melarsoprol levels in serum and in cerebrospinal fluids.
    Maes L; Vanderveken M; Hamers R; Doua F; Cattand P
    Ann Soc Belg Med Trop; 1988 Sep; 68(3):219-31. PubMed ID: 3223784
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of an Alamar Blue viability assay in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427.
    Sykes ML; Avery VM
    Am J Trop Med Hyg; 2009 Oct; 81(4):665-74. PubMed ID: 19815884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of melarsoprol in uninfected vervet monkeys.
    Burri C; Onyango JD; Auma JE; Burudi EM; Brun R
    Acta Trop; 1994 Oct; 58(1):35-49. PubMed ID: 7863853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment.
    Burri C; Keiser J
    Trop Med Int Health; 2001 May; 6(5):412-20. PubMed ID: 11348536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma brucei rhodesiense: use of an antigen detection enzyme immunoassay for evaluation of response to chemotherapy in infected vervet monkeys (Cercopithecus aethiops).
    Gichuki CW; Nantulya VM; Sayer PD
    Trop Med Parasitol; 1994 Sep; 45(3):237-42. PubMed ID: 7899795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of resazurin-based assay in 384-well format for high throughput whole cell screening of Trypanosoma brucei rhodesiense strain STIB 900 for the identification of potential anti-trypanosomal agents.
    Lim KT; Zahari Z; Amanah A; Zainuddin Z; Adenan MI
    Exp Parasitol; 2016 Mar; 162():49-56. PubMed ID: 26772786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propidium iodide-based methods for monitoring drug action in the kinetoplastidae: comparison with the Alamar Blue assay.
    Gould MK; Vu XL; Seebeck T; de Koning HP
    Anal Biochem; 2008 Nov; 382(2):87-93. PubMed ID: 18722997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of 2,3-dimercaptopropinol (British anti-lewisite, BAL) in the trypanocidal activity of topical melarsoprol.
    Jennings FW; Atouguia JM; Murray M
    Acta Trop; 1996 Oct; 62(2):83-9. PubMed ID: 8988309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.